Chemistry and pharmacokinetics of diarylthiophenes and terphenyls as selective COX-2 inhibitors

被引:34
|
作者
Pinto, DJP
Copeland, RA
Covington, MB
Pitts, WJ
Batt, DG
Orwat, MJ
Lam, GN
Joshi, A
Chan, YC
Wang, S
Trzaskos, JM
Magolda, RL
Kornhauser, DM
机构
[1] DuPont Merck Pharmaceutical Company, Wilmington, DE 19880
关键词
D O I
10.1016/S0960-894X(96)00513-6
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
DuP697, 2-bromo-4-(4'-sulfonylmethyl)phenyl-5-(4'-fluoro)phenylthiophene, is a selective type 2 cyclooxygenase (COX-2) inhibitor. Its relatively weak COX-2 selectivity coupled with a poor human pharmacokinetic profile led us to seek improvements on the in vitro selectivity while at the same time, addressing some of its pharmacokinetic liabilities. In this paper we discuss some strategies at solving the PK issue within a class of COX-2 inhibitors. The result of these efforts led to the discovery of a new class of COX-2 inhibitors the terphenyls, which prove to be superior alternatives to the diarylthiophenes. Copyright (C) 1996 The DuPont Merck Pharmaceutical Company. Published by Elsevier Science Ltd
引用
收藏
页码:2907 / 2912
页数:6
相关论文
共 50 条
  • [1] 3,4-DIARYLTHIOPHENES ARE SELECTIVE COX-2 INHIBITORS
    BERTENSHAW, SR
    TALLEY, JJ
    ROGIER, DJ
    GRANETO, MJ
    ROGERS, RS
    KRAMER, SW
    PENNING, TD
    KOBOLDT, CM
    VEENHUIZEN, AW
    ZHANG, Y
    PERKINS, WE
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (23) : 2919 - 2922
  • [2] SYNTHESIS AND BIOLOGICAL EVALUATION OF 2,3-DIARYLTHIOPHENES AS SELECTIVE COX-2 AND COX-1 INHIBITORS
    LEBLANC, Y
    GAUTHIER, JY
    ETHIER, D
    GUAY, J
    MANCINI, J
    RIENDEAU, D
    TAGARI, P
    VICKERS, P
    WONG, E
    PRASIT, P
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (18) : 2123 - 2128
  • [3] SELECTIVE IN-VITRO INHIBITION OF CYCLOOXYGENASE-2 (COX2) BY DIARYLTHIOPHENES AND TERPHENYLS
    PINTO, DJP
    COPELAND, R
    COVINGTON, M
    ORWAT, MJ
    PITTS, W
    JETTER, J
    BATT, DG
    WANG, SI
    GIANNARAS, J
    ANDREWS, T
    NURNBERG, S
    WEXLER, RR
    TRZASKOS, J
    MAGOLDA, R
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 18 - MEDI
  • [4] Pharmacokinetics of the selective COX-2 inhibitors celecoxib and mavacoxib in cockatiels
    Antonissen, G.
    Devreese, M.
    De Baere, S.
    Martel, A.
    Goessens, T.
    Haesendonck, R.
    De Backer, P.
    Croubels, S.
    [J]. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2015, 38 : 103 - 103
  • [5] Selective inhibitors of COX-2
    不详
    [J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 1996, 6 (01) : 79 - 80
  • [6] Selective COX-2 inhibitors
    Parnham, MJ
    [J]. DRUG NEWS & PERSPECTIVES, 1997, 10 (03) : 182 - 187
  • [7] Selective COX-2 inhibitors
    Lloyd, AW
    [J]. DRUG DISCOVERY TODAY, 1997, 2 (03) : 122 - 122
  • [8] Selective COX-2 inhibitors
    Pasero, C
    McCaffery, M
    [J]. AMERICAN JOURNAL OF NURSING, 2001, 101 (04) : 55 - 56
  • [9] Synthesis and biological evaluation of 2,3-diarylthiophenes as selective Cox-2 inhibitors .2. Replacing the heterocycle
    Gauthier, JY
    Leblanc, Y
    Black, WC
    Chan, CC
    Cromlish, WA
    Gordon, R
    Kennedey, BP
    Lau, CK
    Leger, S
    Wang, ZY
    Ethier, D
    Guay, J
    Mancini, J
    Riendeau, D
    Tagari, P
    Vickers, P
    Wong, E
    Xu, LJ
    Prasit, P
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (01) : 87 - 92
  • [10] COX-2 selective inhibitors and bone
    Goodman, SB
    Ma, T
    Genovese, M
    Smith, RL
    [J]. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2003, 16 (03): : 201 - 205